Business Wire | August 28, 2020
Haymarket Media, Inc, a leading provider of clinical information for healthcare professionals, is pleased to announce a partnership with Expertscape Inc, the preeminent source for ranking and finding medical experts across more than 29,000 biomedical topics. The Haymarket Medical Network (HMN) is a digital platform of 19 medical brands delivering a drug database, features, CME, diagnostic information, and point-of-care tools to assist healthcare professionals (HCPs) in the decision making process. Each month hundreds of thousands of HCPs visit the brands in the HMN to engage with trusted content, created by an experienced team of medical journalists and clinicians.Expertscape uses a proprietary algorithm to identify the most knowledgeable physicians in the world by specific disease states. This 100% objective process identifies and ranks experts based on published scientific articles, not on patient rankings, search results or other subjective methods. Expertscape allows physicians to identify the real medical experts for referrals and consults by disease and patients to find options for a second opinion. The results can be sorted by geographic location and medical center so nearby physicians are easy to identify. Expertscape already has significant organic traffic, which will grow faster as part of this partnership.
GE Healthcare | October 12, 2020
GE Healthcare today announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid1 cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently. Methodical assessments of heart function are key in echocardiography but can be tedious and time-consuming to acquire. High quality data acquisition and operator skill are key elements to achieve accurate and complete exams. And, as patients undergo subsequent monitoring exams, the reproducibility of exam assessments is key to identifying improvement or disease progression. Vivid Ultra Edition brings increased efficiencies to the scanning process for reduced exam time through up to 80% fewer clicks3, 99% accuracy4 and less inter-operator variability.
Tegria | June 28, 2021
Tegria announced today the purchase of KenSci, a leader in artificial intelligence systems and healthcare applications with origins in Microsoft's Azure4Research program and the University of Washington.
KenSci, which was founded in 2015, has received recognition for its AI platform and solutions that integrate the latest descriptive and predictive analytics technology, assisting healthcare organizations in modernizing their workflows and powering a digital, data-driven, value-based healthcare system. Customers of KenSci, which include providers, payers, and medical device manufacturers, are using advanced analytics and artificial intelligence in their operational, clinical, and care workflows, thus enhancing care experiences and health outcomes. KenSci applications are based on responsible and explainable AI models that aid in making healthcare more efficient, fair, and accountable.
Its services are cloud-based and built on Microsoft Azure. Customers of KenSci have also benefitted from the company's strong relationships with industry leaders. In 2020, Microsoft honored KenSci, its US Healthcare Partner of the Year.
"Unlocking data to provide insights is the key to making healthcare better for everyone," said Wasif Rasheed, Providence's chief revenue and growth officer. Tegria is set to debut in October 2020. "KenSci has been assisting clients in getting more out of their data for many years, and they understand the critical roles that innovation and collaboration play in accelerating change across all aspects of care. KenSci, when combined with Tegria's industry expertise and a wide variety of solutions, has the potential to have a significant effect on healthcare worldwide. KenSci has arrived in Tegria, and we couldn't be happier."
KenSci's AI-powered platform draws insights from data, resulting in improved patient experiences, more accurate diagnoses, and more efficient processes. KenSci automates data preparation across many sources, including real-time and unstructured data, and maps it into the industry-standard schema, preparing it for machine learning models. KenSci's platform is also designed to be versatile and customizable, allowing clients to build their applications.
"If you can predict, you have the potential to influence and enhance health outcomes," stated Sudarshan Chitre, CEO of KenSci. "AI and advanced analytics technologies are changing how healthcare companies use data to enhance human health and care outcomes. Tegria will allow us to expedite this transition on a larger scale while also providing instant value to our clients via AI-driven insights. We are thrilled to be joining Tegria so that we may write the next chapter together."
KenSci's technology is supported by substantial peer-reviewed research published by The Institute of Electrical and Electronics Engineers (IEEE), The Association for Computing Machinery (ACM), The American Medical Informatics Association (AMIA), and other organizations. KenSci received HIMSS Health Innovation Awards in 2018 and 2019 and KLAS top ratings in healthcare AI in 2019 and 2020. KenSci was a Gartner Cool Vendor and a CMS AI Challenge finalist in 2019. KenSci is headquartered in Seattle and has offices in Singapore and India.
With KenSci, Tegria can expand the breadth and depth in electronic health record optimization, managed services, revenue cycle management, and other areas. KenSci will continue to serve its existing client base while also working with its new colleagues on integrated solutions for the global healthcare industry.
Tegria's financial advisor was Cascadia Capital, and its legal counsel was McDermott Will & Emery on this deal. Brentwood Capital Advisors served as the exclusive financial adviser for KenSci, while Wilson Sonsini Goodrich & Rosati acted as legal counsel.
Tegria, founded by Providence, is dedicated to creating health for a better world. Tegria assists healthcare organizations of all sizes in accelerating technological, clinical, and operational advancements that enable people to live the healthiest lifestyles possible. Tegria is a Seattle-based company with employees throughout the United States and internationally. It employs over 3,000 strategists, technologists, service providers, and scientists committed to providing value to customers.